Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaccines and therapeutics for immunocompromised patients with COVID-19
Shmuel Shoham, Carolina Batista, Yanis Ben Amor, et al.
EClinicalMedicine (2023) Vol. 59, pp. 101965-101965
Open Access | Times Cited: 80

Showing 26-50 of 80 citing articles:

COVID-19: Recent Insight in Genomic Feature, Pathogenesis, Immunological Biomarkers, Treatment Options and Clinical Updates on SARS-CoV-2
Rohitas Deshmukh, Ranjit K. Harwansh, Akash Garg, et al.
Current Genomics (2024) Vol. 25, Iss. 2, pp. 69-87
Open Access | Times Cited: 1
Racial and Ethnic Disparities in COVID-19 Treatments in the United States
Essy Mozaffari, Aastha Chandak, Alpesh Amin, et al.
Journal of Racial and Ethnic Health Disparities (2024)
Open Access | Times Cited: 1
Identification of Dual Inhibitors Targeting Main Protease (Mpro) and Cathepsin L as Potential Anti-SARS-CoV-2 Agents
Santo Previti, Roberta Ettari, Elsa Calcaterra, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 5, pp. 602-609
Closed Access | Times Cited: 1
Impact of Respiratory Viral Infections in Transplant Recipients
Hannah Bahakel, Alpana Waghmare, Rebecca Pellet Madan
Journal of the Pediatric Infectious Diseases Society (2024) Vol. 13, Iss. Supplement_1, pp. S39-S48
Open Access | Times Cited: 1
Documento de posición sobre vacunación COVID-19 en pacientes inmunosuprimidos en todas las etapas de la vida
Florencia Cahn, Laura Barcán, Pablo Bonvehí, et al.
Actualizaciones en Sida e Infectología (2024)
Open Access | Times Cited: 1
An eDElphi STudy to defINe and risk-stratify ImmunosupprESsion: Protocol for the DESTINIES Study (Preprint)
Meredith Leston, José Ordóñez-Mena, Mark Joy, et al.
JMIR Research Protocols (2024) Vol. 13, pp. e56271-e56271
Open Access | Times Cited: 1
Implementation of AZD7442 (Tixagevimab/Cilgavimab) COVID-19 Pre-exposure Prophylaxis (PrEP) in the Largest Health Maintenance Organization in Israel: Real-world Uptake and Sociodemographic and Clinical Characteristics Across Immunocompromised Patient Groups
Samah Hayek, Joseph Levy, Galit Shaham, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 6, pp. 1379-1389
Open Access | Times Cited: 1
SARS-CoV-2 Humoral and Cellular Immune Responses in HIV-Positive Patients
Simona Ruță, Corneliu Petru Popescu, Lilia Matei, et al.
(2024)
Open Access | Times Cited: 1
Efficacy of late-onset antiviral treatment in immune-compromised hosts with persistent SARS-CoV-2 infection
Carolin M. Lieber, Hae-Ji Kang, Elizabeth B. Sobolik, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Retrospective, Observational Analysis on the Impact of SARS-CoV-2 Variant Omicron in Hospitalized Immunocompromised Patients in a German Hospital Network—The VISAGE Study
Irit Nachtigall, Stefan Kwast, Sven Hohenstein, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 634-634
Open Access | Times Cited: 1
Charting a course for global progress in PIDs by 2030 — proceedings from the IPOPI global multi-stakeholders’ summit (September 2023)
Samya Van Coillie, J Prévot, Silvia Sánchez‐Ramón, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
No more government-imposed societal-level COVID-19 control measures but still significant self-experienced burden for severely immunocompromised individuals – A cross-sectional survey in the Netherlands
Jan Pander, Wendy Beekman-Hendriks, Neeltje Coolen, et al.
Preventive Medicine Reports (2024) Vol. 45, pp. 102827-102827
Open Access | Times Cited: 1
Convalescent Plasma for Immunocompromised Patients
Shmuel Shoham
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 1
Efficacy of late-onset antiviral treatment in immunocompromised hosts with persistent SARS-CoV-2 infection
Carolin M. Lieber, Hae-Ji Kang, Elizabeth B. Sobolik, et al.
Journal of Virology (2024) Vol. 98, Iss. 9
Closed Access | Times Cited: 1
Spike and nucleocapsid antibody dynamics following SARS‐CoV‐2 infection and vaccination: Implications for sourcing COVID‐19 convalescent plasma from routinely collected blood donations
Clara Di Germanio, Xutao Deng, Brendan G. Balasko, et al.
Transfusion (2024) Vol. 64, Iss. 11, pp. 2063-2074
Open Access | Times Cited: 1
Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXID
Puran Chen, Peter Bergman, Ola Blennow, et al.
EBioMedicine (2024) Vol. 109, pp. 105385-105385
Closed Access | Times Cited: 1
Estimating the population-level effects of nonpharmaceutical interventions when transmission rates of COVID-19 vary by orders of magnitude from one contact to another
Richard P. Sear
Physical review. E (2024) Vol. 110, Iss. 6
Open Access | Times Cited: 1
A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection
Stephen Boulton, Joanna Poutou, Rida Gill, et al.
Molecular Therapy — Methods & Clinical Development (2023) Vol. 31, pp. 101110-101110
Open Access | Times Cited: 4
Herpes zoster in lupus nephritis: experience on 292 patients followed up for 15 years
Francesco Reggiani, Silvia Cardi, Fabio Tumminello, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
COVID-19: From Emergence to Endemicity - A Comprehensive Review
Roopa Naik, Sreekant Avula, Sujith K Palleti, et al.
(2023)
Open Access | Times Cited: 2
Response to: regarding the significance of anti-COVID-IgA antibody response in COVID-19 breakthrough infection
Sabiha Anis, Mariam Ashfaq Khan, Areej Fatima, et al.
Immunologic Research (2024) Vol. 72, Iss. 3, pp. 366-367
Closed Access
Holistic Care of the Immunocompromised Rheumatologic Patient – Case Analysis
Hannah Moir
EMJ Rheumatology (2024), pp. 2-13
Open Access
Protocol for an e-Delphi study to achieve consensus on a definitive adult immunosuppressed phenotype (Preprint)
Meredith Leston, José Ordóñez-Mena, Mark Joy, et al.
(2024)
Closed Access
Evaluation of SARS-CoV-2 Vaccine-Induced Antibody Responses in Patients with Neuroimmunological Disorders: A Real-World Experience
Hyunjin Ju, Jin Myoung Seok, Yeon Hak Chung, et al.
Diagnostics (2024) Vol. 14, Iss. 5, pp. 502-502
Open Access
Clinician perceptions of research priorities for the management of noncritically ill patients admitted to hospital with SARS‐CoV‐2 infection
Methma Bandara, Lauren A. Barina, Grace McPhee, et al.
Internal Medicine Journal (2024) Vol. 54, Iss. 2, pp. 337-341
Open Access

Scroll to top